search
  • HoLEP: Boosting BPH Treatment Success!

HoLEP: Boosting BPH Treatment Success!

HoLEP: The Worthy Choice for Higher Efficacy and Safety in BPH Treatment

HoLEP: The Worthy
Choice for Higher
Efficacy and Safety in
BPH Treatment

Aim
Aim
Comparing HoLEP and PVP treatments in BPH
Study
Study
Design
Design
Meta-analysis of 11 studies with 4763 BPH patients
Outcomes
Outcomes
  • Efficacy
  • Safety
Qmax
Qmax
PVR
6 months later, HoLEP was better than PVP
MD: -1.69, p=0.04
Energy Consumption
Decreased energy expenditure with HoLEP than PVP
MD: -42.14, p<0.0001
Energy Consumption
Safety: High-Grade Complications
Fewer with HoLEP than PVP
OR: 0.05, p=0.0005
Safety: High-Grade Complications
Safety: Reintervention Requirement
Safety: Reintervention Requirement
Further Benefits
  • HoLEP also offers maintenance of sexual function over PVP.
Conclusion
Conclusion
HoLEP reported higher efficacy and safety than PVP for BPH treatment.

Abbreviations▼

BPH: Benign prostatic hyperplasia; CI: Confidence interval; HoLEP: Holmium laser enucleation of the prostate; IV: Inverse variance; MD: Mean difference; MH: Mantel-Haenszel random-effects model; OR: Odds ratio; PVR: Postvoid residual urine volume; PVP: Photoselective greenlight vaporization; Qmax: Maximum flow rate.

References ▼

Wang Z, Tan Z, Qiu M, et al. A meta-analysis comparing treatment of benign prostatic hyperplasia with holmium laser enucleation and photoselective greenlight vaporization. Current Urology. 2024;1–8.

LMRC Code: GGI-CO-A1-AQS-300020632-BANNERS-G24-0884

 

 

 

 

 

 

 

 

 

 

 

 

 

Alfoo-Improved Pharmacokinetics

ALFOO, containing  Alfuzosin molecule, is Anti-BPH which helps in treatment of LUTS due to BPH in Young Sexually Active Male in 40-60 year old age group

Know more
Alfoo banner

Related Articles

Minimally Invasive BPH/LUTS Surgeries: Why Do They Attract More Attention Than Medical Management ?

Minimally invasive BPH surgeries vs. medical therapy—watch now!

What Is the Level of Concords and Discords for BPH Consensus Statements Including IPSS Relevance?

Immediate Insights: Clinician Debates on BPH

When’s the Right Time to Prescribe Alpha Blockers & 5-Alpha Reductase Inhibitor Combination for BPH?

Unlock the clinical timing of AB + 5-ARI for BPH treatment.

What Patient Queries About Alpha Blockers Do You Encounter While Managing BPH?

Daily vs. alternate-day dosing—patients want answers.

Are All BPH/LUTS Treatments Created Equal, or Is it Time to Consider A More Personalized Approach?

Explore the need for personalized BPH management.

Addressing the Role of Combination Therapies for Medical Management of LUTS

Building and Preserving Wealth - Key Challenges

From Stethoscope to Smartphone

RenalTransplant MPCG

Urethroplasty Updates - Interesting Case Presentations

Efficacy of Tamsulosin 0.4 mg versus 0.8 mg in the treatment of lower urinary tract symptoms associated with benign prostatic enlargement

Patients who receive a double J substitution with a pigtail suture stent experience a reduction in symptoms associated with the stent

Low-intensity shockwave therapy for managing persistent storage symptoms following transurethral surgery for benign prostatic obstruction

Stent on a string: a potential new gold standard for postureteroscopy ureteral drainage

Combination of tamsulosin and Pentoxifylline vs. tamsulosin alone in the treatment of lower urinary tract symptoms caused by benign prostate hyperplasia

Algorithmic Approach to Benign Prostatic Hyperplasia

Building and Preserving Wealth - Key Challenges

Retrograde IntraRenal Surgery (RIRS) by Dr Varinder Singh Attri

Tricks and Tips for Retrograde IntraRenal Surgery (RIRS) by Dr. Anwar Ali

Over Active Bladder - An Overview by Dr Krishna Kumar Sharma